Treatment Methods / Alternatives

Wednesday, September 22, 2010

Google Alert - cell lung cancer

News13 new results for cell lung cancer
 
'Synthetic lethality' strategy improves molecularly targeted cancer therapy
EurekAlert (press release)
... at Fox Chase is launching a trial testing the EGFR inhibitor erlotinib with an Aurora kinase inhibitor in patients with non-small cell lung cancer. ...
See all stories on this topic »
Diabetes drug could suppress cancer cells
Tampabay.com
A presentation at the American Association for Cancer Research in April reported that metformin appears to prevent lung cancer in smokers. ...
See all stories on this topic »
Vegetables, fruits lower lung cancer risk
DoctorNDTV
... chances of getting lung cancer, and a variety of fruits and vegetables may lower the risk of squamous cell lung cancer, especially among smokers. ...
See all stories on this topic »

DoctorNDTV
Roche provides results on Avastin in adjuvant colon cancer
PipelineReview.com (press release)
Avastin is approved in the US and Europe for the treatment of advanced stages of colorectal cancer, breast cancer, non-small cell lung cancer and kidney ...
See all stories on this topic »
A New Way To Find Cancer Drugs
Forbes (blog)
Erbb1, otherwise known as EGFR, is the target of drugs like Tarceva for lung cancer (Roche) and Erbitux for colon cancer (Eli Lilly and Bristol-Myers Squibb ...
See all stories on this topic »
Arch Biopartners Acquires Option to License Anti Cancer Compounds From ...
MarketWatch (press release)
In pre-clinical studies involving mice, these compounds have shown efficacy in slowing the progression of pancreatic cancer, non small cell lung cancer, ...
See all stories on this topic »
Use of anchorchip-time-of-flight spectrometry technology to screen tumor ...
7thSpace Interactive (press release)
Background The purpose of this study is to discover potential biomarkers in serum for the detection of small cell lung cancer (SCLC). ...
See all stories on this topic »
Peregrine Provides Update On Government-Sponsored Research
BioResearch Online (press release)
Bavituximab is currently in two Phase IIb clinical trials for non-small cell lung cancer (NSCLC), three Phase II clinical trials in NSCLC and advanced ...
See all stories on this topic »
Biomarkers in Cancer Research 2010
PRLog.Org (press release)
This growth is primarily attributed to the rise in the number of biomarker tests in the cancer types such as cervical cancer, NSCLC (non-small cell lung ...
See all stories on this topic »
NASDAQ Most active stocks (AVNR, BSDM, NTWK, CTIC)
Penny Stock Live
... and immunological disorders; OPAXIO, a Phase III clinical trial product for the treatment of ovarian, esophageal, and non-small cell lung cancer; ...
See all stories on this topic »
Roche's Avastin Fails in Early-Stage Colon Cancer Study
DailyFinance
Avastin -- which was first approved for metastatic colorectal cancer in 2004, and later for non-small cell lung cancer, metastatic kidney cancer, ...
See all stories on this topic »
LabCorp's Acquisition of Genzyme Genetics Adds to Oncology Molecular Dx Assets
GenomeWeb Daily News
... including testing for ALK gene rearrangements in non-small cell lung cancer; BCR/ABL analysis by real time PCR; FISH testing in multiple myeloma; ...
See all stories on this topic »
Hot NASDAQ performers (LSCC, CYCC, LTXC, UTSI)
Penny Stock Live
... T-cell lymphoma, and lung cancer; Seliciclib (CYC202), a CDK (cyclin dependent kinase) inhibitor, which is in phase II studies for the treatment of lung ...
See all stories on this topic »


This as-it-happens Google Alert is brought to you by Google.

Remove this alert.
Create another alert.
Manage your alerts.

1 comment:

  1. Really lung cancer is the number-one cause of cancer deaths in both men and women in the U.S. and worldwide. Thanks for posting!!!

    Lung cancer treatment

    ReplyDelete